Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Tamoxifen × Breast × Clear all

Phase

Status

Completed 133 Unknown 45 Recruiting 26 Active not recruiting 24 Terminated 20 Not yet recruiting 5 Withdrawn 2 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Paclitaxel 3 Cyclophosphamide 3 Trastuzumab 2 High-Energy Shock Waves 2 Fluorouracil 2 Biopsy 2 trastuzumab biosimilar HLX02 1 tivozanib 1 taletrectinib 1 palbociclib 1 fluzoparib 1 fludarabine 1 exemestane 1 eribulin 1 binimetinib 1 atezolizumab 1 aldesleukin 1 Tomography, Optical Coherence 1 Testosterone Propionate 1 Testosterone 1 Taxes 1 Tamoxifen 1 Tablets 1 Receptors, Chimeric Antigen 1 Radiotherapy 1 PF-05280014 1 Ontruzant 1 Ogivri 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡